The companies did not provide financial terms of the new
contract.
On Tuesday, CVS said the companies had failed to agree on
pricing and that Walmart was leaving the pharmacy network for
the prescription drug plans that CVS manages for companies and
health insurers and for the Medicaid program for low income
people.
The companies also said on Tuesday they were still in
discussions.
CVS shares gained 1.6 percent to $64.76 in premarket trading,
recouping some of its Tuesday losses.
"We view the agreement positively for CVS," Cantor Fitzgerald
analyst Steven Halper said in a research note, explaining that
the loss of Walmart pharmacies could have negatively impacted
CVS' ability to sign customers for its 2020 prescription drug
plans.
In addition to its retail pharmacies and stores, CVS is one of
the country's biggest pharmacy benefit managers and, after
buying Aetna, one of its top health insurance companies. Its
prescription plans for the Medicare population were unaffected
by the contract dispute as was its Sam's Club agreements.
Walmart senior vice president Sean Slovenski described the terms
as "fair and equitable" in a press release.
(Reporting by Caroline Humer in New York and Ankur Banerjee in
Bengaluru; Editing by Shounak Dasgupta and Chizu Nomiyama)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|